Old Web
English
Sign In
Acemap
>
authorDetail
>
Julie Fasano
Julie Fasano
Icahn School of Medicine at Mount Sinai
Internal medicine
Medicine
Pathology
Oncology
Breast cancer
4
Papers
13
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Optimism and coping: do they influence health outcomes in women with breast cancer? A systemic review and meta-analysis.
2020
Breast Cancer Research and Treatment
Julie Fasano
Theresa Shao
Hsin-Hui Huang
Alaina J Kessler
Olivia Kolodka
Charles L. Shapiro
Show All
Source
Cite
Save
Citations (10)
Results of a phase Ib study investigating durvalumab in combination with eribulin in patients with metastatic HER2-negative breast cancer and recurrent ovarian cancer.
2020
Journal of Clinical Oncology
Chrystal Ann Landry
Meng Ru
Christopher Hickson
Paula Klein
Julie Fasano
Aarti Sonia Bhardwaj
Charles L. Shapiro
Hanna Y. Irie
T. Shao
Isaiah Selkridge
Amy Tiersten
Show All
Source
Cite
Save
Citations (0)
A phase Ib study evaluating the safety and tolerability of durvalumab in combination with eribulin in patients with HER2-negative metastatic breast cancer and recurrent ovarian cancer.
2018
Journal of Clinical Oncology
Chrystal Ann Landry
Jeannette Marcelle Guziel
Meng Ru
Charles L. Shapiro
Julie Fasano
Aarti Sonia Bhardwaj
Hanna Y. Irie
Nina Bhardwaj
Amy Tiersten
Show All
Source
Cite
Save
Citations (2)
A multicenter, phase I/II trial of anastrozole, palbociclib, trastuzumab and pertuzumab in HR-positive, Her2-positive metastatic breast cancer.
2018
Journal of Clinical Oncology
Krystal Pauline Cascetta
Poulikos I. Poulikakos
Charles L. Shapiro
Aarti Sonia Bhardwaj
Julie Fasano
Hanna Y. Irie
Paula Klein
Anupama Goel
Kevin Kalinsky
Sylvia Adams
Eleni Andreopoulou
Shabnam Jaffer
Meng Ru
Amy Tiersten
Show All
Source
Cite
Save
Citations (1)
1